The global neurovascular devices market is expected to grow at a CAGR of 10.3% in the first half of the forecast period. In 2016, the Cerebral Embolization and Aneurysm Coiling Devices segment held the largest share in the global neurovascular devices market.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 152-page report you will receive 85 charts– all unavailable elsewhere.
The 152-page report provides clear detailed insight into the global neurovascular devices market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Neurovascular Devices market forecasts to 2027
• This report also breaks down the revenue forecast for the global neurovascular market by submarket – Cerebral Embolization and Aneurysm Coiling Devices – Cerebral Angioplasty and Stenting Systems – Support Devices – Neurothrombectomy Devices
• This report provides individual revenue forecasts to 2027 for these regional and national markets: – The US – EU5: Germany, France, the UK, Italy, Spain – Japan – BRIC: Brazil, Russia, India, China – Rest of the World (RoW)
• Our study gives qualitative analysis of the neurovascular devices market. It discusses the SWOT analysis of the neurovascular devices market.
• Our study discusses the selected leading companies that are the major players in the neurovascular devices industry: – Stryker Corporation – Medtronic – Johnson & Johnson – Terumo – Penumbra
Visiongain’s study is intended for anyone requiring commercial analyses for the global b neurovascular devices market. You find data, trends and predictions.
Buy our report today Global Neurovascular Devices Market Forecast to 2027: Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Support Devices, Neurothrombectomy Devices.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview 1.1 Global Neurovascular Devices Market Overview 1.2 Why You Should Read This Report 1.3 How This Report Delivers 1.4 Key Questions Answered by This Analytical Report Include: 1.5 Who is This Report For? 1.6 Methodology 1.6.1 Primary Research 1.6.2 Secondary Research 1.6.3 Market Evaluation & Forecasting Methodology 1.7 Frequently Asked Questions (FAQ) 1.8 Associated Visiongain Reports 1.9 About Visiongain
2. Introduction to Neurovascular Diseases 2.1 Overview 2.2 Stroke 2.2.1 Types of Strokes 2.2.1.1 Ischaemic stroke: 2.2.1.2 Haemorrhagic stroke: 2.3 Cerebral Artery Stenosis 2.3.1 Diagnosis 2.3.2 Treatment of Cerebral Artery Stenosis 2.3.2.1 Angioplasty 2.3.2.2 Cerebral artery bypass 2.4 Cerebral Aneurysm 2.4.1 Causes of Cerebral Aneurysm 2.4.2 Types of Aneurysms 2.4.3 Prevalence of Aneurysms 2.4.4 Diagnosis of Aneurysms 2.4.5 Treatment of Aneurysms 2.5 Arteriovenous Malformation and Fistulas 2.5.1 Types of AVMs 2.5.2 Epidemiology 2.5.3 Diagnosis of AVM 2.5.4 Treatment of AVMs
3. Global Neurovascular Devices Market Forecast to 2027 3.1 The Global Neurovascular Devices Market Forecast to 2027
4. Leading Neurovascular Devices Submarket Forecast to 2027 4.1 Devices Composition of the Global Market in 2016 and 2027 4.2 Leading Devices Markets for Neurovascular Devices Forecast to 2027 4.2.1 Cerebral Embolization and Aneurysm Coiling Devices 4.2.1.1 Cerebral Embolization and Aneurysm Coiling Devices Market Forecast to 2027 4.2.2 Cerebral Angioplasty and Stenting Systems 4.2.2.1 Cerebral Angioplasty and Stenting Systems Market Forecast to 2027 4.2.3 Support Devices 4.2.3.1 Support Devices Market Forecast to 2027 4.2.4 Neurothrombectomy Devices 4.2.4.1 Neurothrombectomy Devices Market Forecast to 2027
5. Neurovascular Devices: Leading Regional and National Market Forecast to 2027 5.1 Regional Composition of the Global Market in 2016 and 2027 5.3 Leading Regional and National Markets for Neurovascular Devices Market Forecast to 2027 5.3.1 US Neurovascular Devices Market Forecast to 2027 5.3.1.1 The US Will Dominate Throughout the Forecast Period 5.3.1.2 US Neurovascular Devices Market Forecast to 2027 5.3.2 EU5 Neurovascular Devices Market Forecast to 2027 5.3.2.1 German Neurovascular Devices Market: Leader in EU, but Facing Big Reforms 5.3.2.1.1 German Neurovascular Devices Market Forecast to 2027 5.3.2.2 French Neurovascular Devices Market: Strong National Healthcare System, Despite Economic Woes 5.3.2.2.1 French Neurovascular Devices Market Forecast to 2027 5.3.2.3 Italian Neurovascular Devices Market 5.3.2.3.1 Italian Neurovascular Devices Market Forecast to 2027 5.3.2.4 UK Neurovascular Devices Market: Pricing is a Key Issue, Providing Restraints to Revenues 5.3.2.4.1 UK Neurovascular Devices Market Forecast to 2027 5.3.2.5 Spanish Neurovascular Devices Market 5.3.2.5.1 Spanish Neurovascular Devices Market Forecast to 2027 5.3.3 Japanese Neurovascular Devices Market 5.3.3.1 Japanese Neurovascular Devices Market Forecast to 2027 5.3.4 BRIC Neurovascular Devices Market Forecast to 2027 5.3.4.1 China Neurovascular Devices Market: Rapid Growth Will Make it one of the Major Global Players 5.3.4.1.1 China Neurovascular Devices Market Forecast to 2027 5.3.4.2 Brazilian Neurovascular Devices Market: Taken Great Strides Forward with Healthcare 5.3.4.2.1 Brazilian Neurovascular Devices Market Forecast to 2027 5.3.4.3 Russian Neurovascular Devices Market: Punches Below its Weight 5.3.4.3.1 Russian Neurovascular Devices Market Forecast to 2027 5.3.4.4 Indian Neurovascular Devices Market 5.3.4.4.1 Indian Neurovascular Devices Market Forecast to 2027 5.3.5 Rest of the World (ROW) 5.3.5.1 ROW Neurovascular Devices Market Forecast, 2016-2027
6. SWOT Analysis of the Neurovascular Devices Market 6.1 Strengths 6.1.1 Aging Population 6.1.2 Rising Incidence of Obesity 6.1.3 High Incidence of Strokes 6.1.4 Increasing Demand for Minimally Invasive Procedures 6.1.5 Technological Advancements 6.2 Weakness 6.2.1 Disadvantages of Neurovascular Devices 6.3 Opportunities 6.3.1 Healthcare expenditures 6.4 Threats 6.4.1 High Cost of R&D Activities
7. Leading Companies 7.1 Stryker Corporation 7.1.1 Introduction 7.1.2 Recent Performance Analysis 7.1.3 Total Company Sales by Business Segments,2016 7.1.4 Stryker Products 7.2 Medtronic 7.2.1 Introduction 7.2.2 Recent Performance Analysis 7.2.3 Total Company Sales by Business Segments,2017 7.2.4 Medtronic Products 7.3 Johnson & Johnson 7.3.1 Introduction 7.3.2 Recent Performance Analysis 7.3.3 Total Company Sales by Business Segments,2016 7.3.4 Johnson & Johnson Products 7.4 Terumo 7.4.1 Introduction 7.4.2 Recent Performance Analysis 7.4.3 Total Company Sales by Business Segments,2016 7.4.4 Terumo Products 7.5 Penumbra 7.5.1 Introduction 7.5.2 Recent Performance Analysis 7.5.3 Total Company Sales by Business Segments,2016 7.5.4 Penumbra Products
8. Conclusion 8.1 Neurovascular Devices Market Forecast 8.2 The US has the Largest Share 8.3 Cerebral Embolization and Aneurysm Coiling Devices Dominates the Neurovascular Devices Market
Appendices Associated Visiongain Reports Visiongain Report Sales Order Form Appendix A About Visiongain Appendix B Visiongain report evaluation form
List of Figures Figure 3.1 Global Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027 Figure 4.1 Devices Composition of the Global Neurovascular Devices Market: Revenues ($bn), Market Share (%), 2016 Figure 4.2 Devices Composition of the Global Neurovascular Devices Market: Revenues ($bn), Market Share (%), 2027 Figure 4.3 Devices Forecasts for the Global Neurovascular Devices Market: Revenues ($bn), 2016-2027 Figure 4.4 Cerebral Embolization and Aneurysm Coiling Devices Market Forecast: Revenues ($bn), 2016-2027 Figure 4.5 Cerebral Angioplasty and Stenting Systems Market Forecast: Revenues ($bn), 2016-2027 Figure 4.6 Support Devices Market Forecast: Revenues ($bn), 2016-2027 Figure 4.7 Neurothrombectomy Devices Market Forecast: Revenues ($bn), 2016-2027 Figure 5.1 Regional Composition of the Global Neurovascular Devices Market: Revenues ($bn), Market Share (%), 2016 Figure 5.2 Regional Composition of the Global Neurovascular Devices Market: Revenues ($bn), Market Share (%), 2027 Figure 5.3 Regional Forecasts for the Global Neurovascular Devices Market: Revenues ($bn), 2016-2027 Figure 5.4 US Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027 Figure 5.5 German Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027 Figure 5.6 French Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027 Figure 5.7 Italian Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027 Figure 5.8 UK Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027 Figure 5.9 Spanish Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027 Figure 5.10 Japanese Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027 Figure 5.11 Chinese Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027 Figure 5.12 Brazilian Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027 Figure 5.13 Russian Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027 Figure 5.14 Indian Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027 Figure 5.15 ROW Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027 Figure 6.1 Stryker: Sales by Business Segments, 2016 Figure 6.2 Medtronic: Sales by Business Segments, 2017 Figure 6.3 Johnson & Johnson: Sales by Business Segments, 2016 Figure 6.4 Terumo: Sales by Business Segments, 2016 Figure 6.5 Penumbra: Sales by Business Segments, 2016 Figure 8.1 Global Neurovascular Devices Market by Region ($bn) (2016 and 2021) Figure 8.2 Global Neurovascular Devices Market by Region ($bn) (2022 and 2027) Figure 8.3 Global Neurovascular Devices Market by Device Type ($bn) (2016, 2022, 2027)
Angiotech Technologies, Inc Balt Extrusion Biosphere Medical Boston Scientific Corporation Chestnut Medical Technologies Codman Neuro Concentric Medical Cordis Corporation Cork Ltd. Cork, Ireland Covidien Edap Technomed Japan EKOS Endovasix Ev3 Medical FDA Johnson & Johnson Lumen Biomedical, Inc Mauna Kea Technologies Medtronic Invatec Medtronic, Inc Neuravi Omnisonics Medical Technologies Penumbra Pfizer Possis Medical Solution Spectanetics Stryker Corporation Stryker Neurovascular Target Therapeutics Terumo Upjohn
List of Organizations Mentioned in the Report American Heart Association Cambridge University Hospitals NHS Foundation Trust Center for Biologics Evaluation and Research (CBER) Center for Devices and Radiological Health (CDRH) Centers for Disease Control and Prevention (CDC) Central Drug Standards Control Organization (CDSCO) China Food and Drug Administration (CFDA) Department of Health (DoH) Department of Health and Association of the British Pharmaceutical Industry Department of Health and Human Services (HHS) European Federation of Pharmaceutical Industries and Associations (EFPIA) European Union (EU) Federal Food, Drug, and Cosmetic Act (FFDCA) International Society for NeuroVascular Disease Japan's Ministry of Health, Labor and Welfare (MHLW) Medical Device Directive (MDD) Medical Device Regulatory Authority of India (MDRA) National Health Service (NHS) National Institute for Health and Care Excellence (NICE) Oxford University Hospitals Sheffield Teaching Hospitals South London and Maudsley Hospitals SSN (Servizio Sanitario Nazionale) Therapeutic Goods Administration (TGA) University College London Hospitals World Bank
Download sample pages
Complete the form below to download your free sample pages for Global Neurovascular Devices Market Forecast to 2027
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
